Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Active and recent NIH-funded research on Sialidosis Type 2. Data from NIH RePORTER, last 36 months.
Sialidosis Type 2 has emerging NIH research funding with 2 grants totaling $1.8M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Sialidosis Type 2. Strongest funded area: Gene Therapy / Cell Therapy. Largest gap: Basic Science.
6 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for sialidosis type 2. Existing research activity suggests this may be a viable area for grant applications.
8 publications in Basic Science / Preclinical but no NIH-funded grants found in Basic Science for sialidosis type 2. Existing research activity suggests this may be a viable area for grant applications.